Research Paper Volume 13, Issue 2 pp 2780—2802
Identification of a novel immune microenvironment signature predicting survival and therapeutic options for bladder cancer
Figure 8. Construction and validation of a nomogram. (A) Nomogram for predicting the 1, 3, 5, and 10-year survival of UBC patients in the TCGA-BLCA cohort. (B–E) Calibration plot evaluating the consistency of the predicted value of the model and the probability of survival at 1, 3, 5, and 10 years obtained using the aforementioned nomogram.